vhgbx
The most significant message I obtained was the change in the business structure. When the IPO was made MX1 intended manufacturing products using x-ray tubes developed in the USA and manufactured by a Chinese company. These proved the weak link; quality control was lacking and production slow.
Over the last 2 years MX1 have developed the ability to manufacture a superior product in-house at a cheaper price with guaranteed quality. Their technology has been granted international patents
Ann: 2019 AGM Presentation, page-3
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
